Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for sleep quality after gastrointestinal endoscopy
ChiCTR2200063114Phase 4Not yet recruiting
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in sleep disorder (2 arms), sponsored by Affiliated Qingdao Central Hospital of Qingdao University. Primary endpoint: Pittsburgh Sleep Quality Index score change. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2200063114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063114.